Giardia Diagnosis and Treatment

Diagnosis

The American Gastroenterological Association recommends molecular testing (enzyme immunoassay for Giardia antigen or nucleic acid amplification tests) or direct fluorescent antibody testing for suspected giardiasis, which have superior sensitivity and specificity compared to traditional microscopy 1
The Infectious Diseases Society of America suggests testing for Giardia lamblia in patients with persistent or chronic diarrhea (lasting ≥14 days), particularly in travelers returning from endemic areas 2, 3, 4
The American Gastroenterological Association recommends testing for Giardia in patients with diarrhea and bloating, abdominal pain, and weight loss, as well as in high-risk exposures such as drinking untreated water from streams/lakes, daycare center exposure, men who have sex with men, or travel to endemic regions 1
The Infectious Diseases Society of America recommends testing for Giardia in immunocompromised patients with diarrhea as part of a broader parasitic workup 3, 4

Enzyme immunoassay (EIA) for Giardia antigen is a primary testing option with high sensitivity (100%) and specificity (98.9-99.7%) 1
Nucleic acid amplification tests (NAAT) or multiplex PCR panels are excellent performance options that can detect multiple pathogens simultaneously 1, 5
Traditional microscopy (ova and parasite examination) requires 3 stool specimens collected on different days due to intermittent cyst shedding and is less sensitive than molecular methods 1, 5

Cryptosporidium and Giardia testing are often performed together as a combined parasitology examination 6, 7
When using NAAT/PCR, clinical correlation is essential as these tests detect DNA, not necessarily viable organisms 4, 5